For the first time in nearly two decades, a drug has been approved to treat amyotrophic lateral sclerosis, which is commonly referred to as Lou Gehrig’s disease. The drug, Radicava, is only the second drug to be approved by the FDA for this particular disease. In a six month study, Japanese researchers reported that the drug significantly slowed disease progression. Read the full press release here.

Share This